If you consider that this statement satisfies your expectations of full disclosure, more power to you - I am sure you will be happy to sit tight and wait for the company to locate more 'compliant' animal specimens.
Given the apparent fickleness of these critters to cooperate with lab technicians, however, it seems odd to me that they should be so widely adopted within the pharmaceutical industry for this type of testing.
In my opinion, shareholders will never see these results - I may be wrong, of course.
RCE Charts, page-1228
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.5¢ |
Change
-0.010(1.68%) |
Mkt cap ! $120.3M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 58.5¢ | $5.422K | 9.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1152 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 2570 | 3 |
View Market Depth
| Last trade - 11.48am 05/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |